ASX Filings

Ceasing to be a substantial holder

June 2, 2023

Opthea Presents at the Jefferies 2023 Healthcare Conference

May 26, 2023

Opthea participates in EF Hutton hosted webinar on OPT-302

May 18, 2023

Change in substantial holding

May 17, 2023

Opthea Presents at JMP Securities Life Sciences Conference

May 9, 2023

Opthea to Participate at HC Wainwright BioConnect Conference

April 28, 2023

Becoming a substantial holder

March 21, 2023

Opthea Receives A$8.7million R&D Tax Incentive

March 7, 2023

Opthea to participate at Oppenheimer's Healthcare Conference

March 7, 2023

Half Year Accounts

February 23, 2023